Prediction of age at menopause in women with polycystic ovary syndrome

References

• Thomas F, Renaud F, Benefice E, De Meeüs T, Guegan J-F. International variability of ages at menarche and menopause: patterns and main determinants. Hum Biol 2001;73:271–90
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Solaymani-Dodaran M, Hedayati M, Azizi F. Is polycystic ovary syndrome an exception for reproductive aging? Hum Reprod 2010;25:1775–81
   PubMed Web of Science ®Google Scholar
• Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric 2015;18:483–91
   PubMed Web of Science ®Google Scholar
• Depmann M, Eijkemans MJ, Broer SL, et al. Does anti-Mullerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study. Hum Reprod 2016;31:1579–87
   PubMed Web of Science ®Google Scholar
• Christiansen SC, Eilertsen TB, Vanky E, Carlsen SM. Does AMH reflect follicle number similarly in women with and without PCOS? PLoS One 2016;11:e0146739
   PubMed Web of Science ®Google Scholar
• te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141–54
   PubMed Web of Science ®Google Scholar
• Meczekalski B, Czyzyk A, Kunicki M, et al. Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment. J Endocrinol Invest 2016;39:1259–65
   PubMed Web of Science ®Google Scholar
• Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update 2014;20:688–701
   PubMed Web of Science ®Google Scholar
• Kalra SK, Ratcliffe SJ, Dokras A. Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the society for assisted reproductive technology registry to assess the impact of reproductive aging on live-birth rate. Fertil Steril 2013;100:208–13
   PubMed Web of Science ®Google Scholar
• Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: tehran lipid and glucose study phase II. Trials 2009;10:5
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Solaymani-Dodaran M, Azizi F. A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause . Menopause 2009;16:797–802
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metabol 2013;98:729–35
   PubMed Web of Science ®Google Scholar
• Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981;140:815–30
   PubMed Web of Science ®Google Scholar
• Azziz R, Waggoner WT, Ochoa T, Knochenhauer ES, Boots LR. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril 1998;70:274–8
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
   Web of Science ®Google Scholar
• Dolleman M, Faddy M, van Disseldorp J, et al. The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. J Clin Endocrinol Metabol 2013;98:1946–53
   PubMed Web of Science ®Google Scholar
• Royston P, Sauerbrei W. Building multivariable regression models with continuous covariates in clinical epidemiology–with an emphasis on fractional polynomials. Methods Inf Med 2005;44:561–71
   PubMed Web of Science ®Google Scholar
• Cook CL, Siow Y, Brenner AG, Fallat ME. Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril 2002;77:141–6
   PubMed Web of Science ®Google Scholar
• Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 2005;20:1820–6
   PubMed Web of Science ®Google Scholar
• Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC. Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod 2004;19:2036–42
   PubMed Web of Science ®Google Scholar
• Hudecova M, Holte J, Olovsson M, Poromaa IS. Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. Hum Reprod 2009;24:1176–83
   PubMed Web of Science ®Google Scholar
• Brown ZA, Louwers YV, Fong SL, et al. The phenotype of polycystic ovary syndrome ameliorates with aging. Fertil Steril 2011;96:1259–65
   PubMed Web of Science ®Google Scholar
• Carmina E, Campagna AM, Lobo RA. A 20-year follow-up of young women with polycystic ovary syndrome. Obstet Gynecol 2012;119:263–9
   PubMed Web of Science ®Google Scholar
• Elting MW, Korsen TJ, Rekers-Mombarg LT, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 2000;15:24–8
   PubMed Web of Science ®Google Scholar
• Whelan EA, Sandler DP, McConnaughey DR, Weinberg CR. Menstrual and reproductive characteristics and age at natural menopause. Am J Epidemiol 1990;131:625–32
   PubMed Web of Science ®Google Scholar
• Parazzini F. Determinants of age at menopause in women attending menopause clinics in Italy. Maturitas 2007;56:280–7
   PubMed Web of Science ®Google Scholar
• Carolan M. First time mothers over 35 years: challenges for care? Birth Issues 2004;13:91–7
   Google Scholar
• de Kat AC, van der Schouw YT, Eijkemans MJ, et al. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Mullerian hormone decline. BMC Med 2016;14:151
   PubMed Web of Science ®Google Scholar
• Siristatidis C, Sergentanis TN, Vogiatzi P, et al. In vitro maturation in women with vs. without polycystic ovarian syndrome: a systematic review and meta-analysis. PLoS One 2015;10:e0134696
   PubMed Web of Science ®Google Scholar
• Mozumdar A, Agrawal PK. Prevalence, trends, and determinants of menopause in India: NFHS 1992-93 to NFHS 2005-06. Am J Hum Biol 2015;27:421–5
   PubMed Web of Science ®Google Scholar
• van Rooij IA, den Tonkelaar I, Broekmans FJ, et al. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004;11:601–6
   PubMedGoogle Scholar
• Morris TP, White IR, Carpenter JR, Stanworth SJ, Royston P. Combining fractional polynomial model building with multiple imputation. Stat Med 2015;34:3298–317
   PubMed Web of Science ®Google Scholar
• Malcolm CE, Cumming DC. Does anovulation exist in eumenorrheic women? Obstet Gynecol 2003;102:317–18
   PubMed Web of Science ®Google Scholar